Cabozantinib in Advanced Pancreatic Neuroendocrine and Carcinoid Tumors
by on Monday, November 7th, 2011 | No Comments
Conditions: Carcinoid Tumor; Pancreatic Neuroendocrine Tumor
Intervention: Drug: Cabozantinib
Sponsor: Massachusetts General Hospital
Not yet recruiting – verified November 2011
Read more here: Cabozantinib in Advanced Pancreatic Neuroendocrine and Carcinoid Tumors